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Background: Anatomic pathology laboratory workflow consists of 3 major
specimen handling processes. Among the workflow are preanalytic, analytic,
and postanalytic phases that contain multistep subprocesses with great impact
on patient care. A worldwide representation of experts came together to create
a system of metrics, as a basis for laboratories worldwide, to help them
evaluate and improve specimen handling to reduce patient safety risk.
Method: Members of the Initiative for Anatomic Pathology Laboratory Patient
Safety (IAPLPS) pooled their extensive expertise to generate a list of metrics
highlighting processes with high and low risk for adverse patient outcomes.
Results: Our group developed a universal, comprehensive list of 47
metrics for patient specimen handling in the anatomic pathology
laboratory. Steps within the specimen workflow sequence are categorized
as high or low risk. In general, steps associated with the potential for
specimen misidentification correspond to the high-risk grouping and merit
greater focus within quality management systems. Primarily workflow
measures related to operational efficiency can be considered low risk.
Conclusion: Our group intends to advance the widespread use of these
metrics in anatomic pathology laboratories to reduce patient safety risk
and improve patient care with development of best practices and
interlaboratory error reporting programs.
Keywords: anatomic pathology, patient safety, best practices, workflow
metrics
Patient safety issues within the United States health care
system were brought to wide public attention by a report
from the Institute of Medicine (IOM) published in the year
2000.1 The report focused on adverse outcomes from
surgical procedures or medication prescription errors and
revealed an overwhelming number of undetected diagnostic
errors, specifically in the outpatient setting.1 The IOM
report also called for the formation of a federal agency to
lead a unified effort in reducing errors that affect patient
health. It also highlighted a need for anonymous and
standardized reporting, to avoid frivolous malpractice
lawsuits.1,2 One of the focus areas of the outpatient
setting, detailed in the report, was the anatomic pathology
(AP) laboratory.3
Self-monitoring and self-awareness among individual AP
labs resulted in several publications from independent sites
on diagnostic errors.2,4,5 In response to these initial
autonomous efforts, the College of American Pathologists
(CAP) established the Q-probes survey and unified the
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approach to collect AP laboratory workflow errors.6 A Q-
probes survey conducted in the outpatient setting detected
an average error incidence rate of 4.8% among a total of
660 institutions.6 Although accumulative, the Q-probes
survey data continue to reflect errors associated with
practices restricted within the United States and Clinical
Laboratory Improvement Amendments (CLIA)–certified labs.
Q-tracks is a voluntary program launched by CAP to
capture individual laboratory performance for laboratory
services, to track errors and variations in quality.6 The
community based reporting allows individual laboratories to
conduct comparisons and collectively improve best
practices.
Beyond the CAP-officiated Q-probes survey and Q-tracks
program, there were no collective data sets which reflect
worldwide practices within the AP-laboratory workflow.
Recognizing the value of community input, a few laboratories
developed a shared error-reporting database. The Patient
Safety Database was created at the Center of Excellence of
Pathology Quality and Health Care Research, within the
University of Pittsburgh, in Pennsylvania, to collect error data
with 3 partner institutions (ie, Western Pennsylvania
hospitals, the University of Iowa, and Henry Ford Medical
Center).7 The error database was an attempt to provide
measurable data to support resource allocation and decision
making, as well as to provide robust evidence for
implementation of best practices. However, no
comprehensive report was derived from data mining, which
likely happened due to the large collection of unstructured
data and varied deficiencies in the AP laboratory workflow.
The literature suggests that limitations in error reporting are
fundamental to the current culture of health care institutions
in which reluctance to release unfavorable diagnostics data
is ingrained.8,9 To date, these combined challenges have
hindered development of a comprehensive list on AP
workflow process deficiencies for collection of error data.
After the IOM report was released, best estimates suggested
that increased surveillance and accountability reduced the
rate of misdiagnosis; however, issues remain with AP
laboratory processes.10 The AP laboratory setting continues
to be fundamentally challenged by a shrinking workforce.
Essentially, there are fewer histotechnology training
program graduates, and simultaneously, there has been an
increase in retirement of experienced technologists.11 The
strain on resources is offset somewhat as automation
replaces a few manual specimen handling processes.
However, to truly overcome potential challenges, AP
laboratories have proactively adopted the root-cause
analysis (RCA) system to identify the causes of common
error, thus providing better training.12 However, data were
needed to identify those processes most vulnerable to error
that impact patient care, to improve training of the next
generation of histotechnologists. Again, the need arises for a
list of critical metrics for AP laboratory workflow, in the
interest of improving patient care.
Previously, studies concluded that quality issues in the AP
laboratory occurred due in part to the inherent diversity of
specimens and procurement methods.4,12 For example,
delivery or procurement of patient specimens into the AP
laboratory occurs from various sites and often with no
universally shared operating procedures for labeling or
fixation. This and other challenges highlight the need to
develop and implement new universal best practices.
However, once more, there is a need to gather reliable data
before implementation of new processes.
In this study, we identified 47 vulnerable workflow steps that
can cause diagnostic errors within the AP laboratory. We
report these results as a global initiative aimed at identifying
the many potential deficiencies within the AP laboratory
workflow, in the interest of improving worldwide public health.
Materials and Methods
In 2014, a group of AP laboratory management experts
convened as an advisory board for industry. The group
realized the expansive potential to improve AP laboratory
management practices and rapidly assumed a new
independent identity from that of an advocacy group; this
new group called itself the Initiative for Anatomic Pathology
Laboratory Patient Safety (IAPLPS). The group consisted of
highly involved internationally recognized experts in AP
laboratory organization, including pathologists, a laboratory
administrator, and a pathology assistant. Their first position
statement was published in March 2014, calling for an
international effort to secure safe, reliable processing of all
patient specimens for diagnosis.13
Members of this group pooled the experiences of their
respective institutions to identify and rank a comprehensive list
of steps that they perceived to represent patient risk within
the AP laboratory workflow. All 47 metrics were subject to
discussion before members reached a consensus on relative
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risk. Individual members were electronically surveyed with
regard to grading each metric as too high, intermediate, or low
risk for likelihood of adverse patient outcome. High and low
risk groupings were separable, with significant agreement
among the membership. However, a group of intermediate-risk
measures was not distinguishable, thus leading to a final
separation consisting of only high and low risk categories.
Globally harmonized practices and processes within the AP
laboratory helped to generate this set of metrics. This list is
different from Q-probes criteria or other checklists because it
consists of workflow activities that influence risk to patient
care and not only standard quality and efficiency. The list
specifically focuses on safety threats in the AP laboratory
and does not include potential patient safety threats from
pathologist interpretative errors because professional
training and remediation better address these risks. The
scope also excludes preanalytic processes not directly
controlled within the AP laboratory, such as specimen
handling in the surgical or operating suite. Pathologist
interpretation and AP laboratory specimen sourcing remain
important issues for future investigation but are not within
the scope of this research project.
Results
The list in Figure 1 consists of the final set of 47 metrics
generated by members of the IAPLPS. Each item, within each
phase, was a stand-alone metric. The workflow phases
progressed from specimen procurement to completion of the
pathologist report. The parenthetic-alphanumeric designations
indicate the exact succession of steps within each phase. The
3 categories of AP laboratory processing are preanalytic,
analytic, and postanalytic; together, these categories contain
10 independent subprocesses. Figure 1 identifies 26 of 47
metrics as high risk (shown in red) and 21 as low risk (in black).
Exhaustive discussion of this grading led us to realize that in
extraordinarily rare circumstances, almost any step in the AP
laboratory could lead to an adverse patient event. For
example, although typographical discrepancies in the final
report usually only pose a minor threat to misdiagnosis, the
remote possibility exists that mislabeling can result in a
serious medical misdiagnosis. However, although some
metrics raise potential severe patient safety concerns, in most
instances, even in riskier steps, laboratory professionals
avoided actual adverse events by means of early detection.
Figure 1 indicates that we identified high and low risk
processes in all 3 phases. Based on this list, the preanalytic
phase had 9 possible deficiencies for safety in workflow, of
which 4 were designated as high risk. Three metrics listed in
the accessioning process were classified as high risk, and 3
others were considered to present low risk to patient care.
An example of a high risk scenario is when an inadequate
amount of fixative jeopardizes the specimen integrity and
results in the need for another biopsy. Some low risk
process deficiencies listed have mild consequences,
requiring only remedial efforts for resolution, such as correct
pathologist case assignment. Other deficiencies, such as
mislabeling errors, may be resolved immediately further
down the stepwise sequence with limited consequences.
However, most of the metrics listed in this article are capable
of generating an adverse patient outcome if not properly
addressed.
The histotechnology committee affiliated with CAP and the
National Society for Histotechnology (NSH) has recently
updated a guidance document called the Practical Guide to
Specimen Handling in Surgical Pathology.14 This committee
reports to the Council on Scientific Affairs and currently
contains 14 members, of which 6 are CAP fellows and 8 are
certified histotechnologists and American Society for Clinical
Pathology (ASCP) certified. The purpose of the committee is
to provide technical information for the improvement of
laboratory processes. The specimen handling guideline
publication not only identifies process deficiencies but also
provides literature to support the entire workflow. The
publication also discusses patient safety issues, with the
intention to bring about awareness of the Practical Guide to
Specimen Handling. It is an extensive report of the types of
errors in workflow that can occur in the AP laboratory, which
could compromise the quality of the specimen. The report is
full of details associated with various processes. Strict
criteria for specimen procurement transfer are described in
the guide, stating that all containers for specimen material
should be rigid, impermeable, unbreakable, and nonreactive
to fixative solutions.14 Also reported are the fixative
programs for tissue processing, with references to peer-
reviewed manuscripts and to proper waste-management
documents.14 This report provides detailed insights toward
optimal performance. However, its content is extensive and
is not limited to processes with direct impact on patient care,
unlike our metrics list, which focuses on high-risk issues.
Figure 1 suggests that the lengthy analytic phase contains
multiple processes associated with the potential for high risk
Laboratory QA
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Grossing
10 (a) Paent-subject mismatch on 
dictaon
11 (b) Mislabeling of cassees
12 (c) Specimen/ssue 
contaminaon within cassee (as 
introduced by contact with tools, 
equipment or other specimens)
13 (d) Cassees found open or 
empty aer processing
14 (e) Special processing incorrectly 
ordered (eg, rapid for biopsies, 
slow for large fay ssues, etc)
15 (f) Tissue blocks too thick or too 
wide for cassees
16 (g) Incorrect tests ordered (eg, 
special stains, IHC, decal)
17 (h) Incorrect priorizaon 
assigned (eg, rush vs roune)
18 (i) Wrong color coded cassee(s) 
used
19 (j) Slow turnaround me
20 (k) Number of cases remaining 
ungrossed at end of day or shi as 
appropriate
Processing
21 (a) Errors in processing (eg, fluids 
not sufficient for run or incorrectly 
placed)
22 (b) Cross contaminaon of ssues 
between cassees
23 (c) Tissue incompletely decalcified, 
too hard or too so; secons appear 
“burned” or otherwise unsasfactory
24 (d) Interrupons in scheduled runs
Embedding
25 (a) Tissue specimens incorrectly 
paired with cassee; completely or 
in part (manual step permits human 
errors with sample orientaon of 
specimen in cassee)
26 (a) Incorrect case secons on slides
27 (b) Microtomy deficiencies  
(eg, unneccessary depleon of block, 
secons compressed, disrupted or 
wrinkled)
28 (c) Incorrect block orientaon
29 (d) Incorrect seconing protocol 
used
Accessioning
4 (a) Paent-specimen identy 
mismatch
5 (b) Porons of specimen missing or 
anatomic site mismatch
6 (c) Inadequate specimen condion 
(eg, absent or minimal fixave)
7 (d) Incorrect specimen processing 
workflow selected (eg, wrong grossing 
protocol, missed research protocol 
ssue preparaon—note: some labs 
may delay this step unl the grossing 
process)
8 (e) Slow turnaround me
9 (f) Delay in specimen accessioning
Specimen Procurement
1 (a) Sample lost in delivery or empty 
container
2(b) Case assigned to wrong pathologist
3 (c) Incorrect priorizaon assigned  
(eg, rush vs roune handling)
PREANALYTIC PHASE ANALYTIC PHASE
Figure 1
List of the anatomic pathology laboratory workflow metrics surveyed as being high risk and low risk for adverse patient outcomes. Within each
category, the metrics are listed (alphabetically), and all 47 process metrics are listed numerically according to the entire workflow sequence.
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Staining and  
Coverslipping
30 (a) “Floaters” present on slide
31 (b) Inadequacies of 
primary staining compromises 
interpretaon
32 (c) Inadequate quality of 
convenonal special stains
33 (d) Inadequate quality of IHC or 
ISH slides and/or controls
34 (e) Coverslipping errors (eg, 
bubbles, scratches, missing 
coverslip)
Case Assembly
35 (a) Slides mismatched or 
missing for parcular case
36 (b) Delay in case assembly 
without cause (eg, held for special 
stains that have already been sent 
to pathologist)
37 (c) Slow turnaround me
38 (d) Insufficient management of 
case load
Pathologist Signout
39 (a) Dictaon case mismatch, total 
or in part (eg, addendum to different 
case)
40 (b) Specimen related errors  
(eg, deficiencies in quality of slide or 
ssue contaminants not appreciated)
41 (c) Typographical/proofreading 
deficiencies
42 (d) Slow turnaround me for enre 
case signout




44 (a) Mislabeled or missing slide or 
cassee (with hand labeleing)
45 (b) Specimen labeling errors, 
including separate or subsequently 
submied porons
46 (c) Mismatch in frozen secon 
log book
47 (d) Slow turnaround me 
 (eg, threshold is ±20 minutes)
POSTANALYTIC PHASE
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to patients. Features such as processing, staining, and
coverslipping specifically contain high risk metrics. Similar to
those in the preanalytic phase, most metrics in the analytic
phase have the potential to lead to misdiagnosis, if not
carefully designed and monitored. Possible solutions to
reduce error include advanced automation using individual
slide-staining technology and coverslipping, to avoid any
cross-contamination among specimens. The potential for
error associated with the processing subgroup can be readily
addressed with implementation of best practices.
Specifically, adhering to proper sequence timing (ie,
incorporating tissue type specifications) and performing
maintenance of fresh stock reagents will greatly minimize
risk.
As highlighted in the final phase of the AP laboratory
workflow, the postanalytic phase contains 2 distinct
subprocesses. Within these, 6 of the 9 metrics are high risk,
indicating that some are closely associated with patient
safety. The first process was the pathologist sign-out and the
second was grouping of intraoperative procedures
associated with frozen sections. Similar to the previous
phases, some metrics listed under pathologist sign-out can
be corrected with use of automated equipment. For example,
the metric of dictation case mismatch can be resolved if the
pathologist report is electronically integrated with audio-file
compatibility, thus synchronizing the report with the
dictation. Some metrics listed in Figure 1 may have
established, relatively simple solutions, but others continue
to present challenges, which calls for a worldwide effort to
compile error data before construction of best practices.
Conclusions
Management of the AP laboratory requires a dedicated
effort from health care staff and pathologists, to avoid
diagnostic error and patient mismanagement. The
challenge is to obtain measureable quality improvements in
specimen workflow, reducing risk of adverse outcomes in
patient care. The metrics list generated in this study is a
comprehensive tool for standardizing collection of quality
metrics, derived from pooled experience and expertise. The
metrics list, in combination with collection of error data,
allows a comprehensive approach to initiate an engaged
collaborative dialogue and to reduce risk of adverse
outcomes from the AP laboratory workflow. Ultimately,
doing this will require support and participation from patient
care areas outside the laboratory, particularly those
submitting tissue specimens. Surgical suites and other
sites, such as gastrointestinal endoscopic and gynecologic
clinics, would need to be involved. Implicit in such a
scenario is the direct support of health care facility officers,
patient safety officers, and other stakeholders, possibly
even including patients.
The key objective of the IAPLPS in publishing this list of
47 metrics is to increase data collection regarding
workflow deficiencies. In the past few decades since the
release of the IOM Report, several individual laboratories
in the academic and private sectors have published their
collection of error data.15,16 However, to our knowledge,
only our report contains a list of error metrics composed
by a team of global experts from 6 different countries.
The metrics listed herein are universal and more
comprehensive than those represented in the Q-probes
survey, as well as being inclusive of intraoperative-
procedure components.7
This list of metrics also requires a proactive style of
management for improvement of the AP laboratory workflow
systems. Because specimen procurement is the beginning of
the workflow, it is essential for harmonious cooperation to
take place during that step among nonlaboratory health care
professionals and institutional administrators. Also, the
metrics include risks with pathologist interpretation that
continue to remind pathologists to integrate with the AP
laboratory workflow before receipt of diagnostics slides. In
the past, individual laboratories have attempted to borrow
management practices from other fields, such as the Lean
principles.17,18 Some have utilized the concept of Lean
production methods to streamline and quantitate error data
into measurable metrics within the AP laboratory with
positive results.15
However, not all laboratories generate the same volume of
specimens. Also, not all laboratories have the resources to
approach all 47 metrics at once; more data would be
beneficial in selecting solutions that are high in priority but
low in cost. Grading of the metrics into higher and lower risk
allows prioritization for lower initial cost expenditures. The
set of metrics that we present herein will provide a
framework from which management can collect data and
justify the cost of implementing quality improvement
systems.
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Many of the metrics listed herein are more readily resolved
with the installation of advanced technology, such as
barcode readers, specimen-tracking instruments,
computerized organizational systems, or advanced
automated staining systems. However, in some instances,
simple solutions are just as effective. For example in a recent
report from the Department of Dermatology at Duke
University Medical Center, misplacement of patient biopsy
specimens was identified as a major problem within the
workflow.19 Requiring attachment of a sticker to each
specimen container, along with the initials of the person who
had performed the specimen-retrieval procedure, reduced
the error rate from 5.79 to 3.53 per 1000 cases.19 Thus, by
increasing traceable individual accountability, the laboratory
achieved dramatic improvement in an area of critical risk to
patient safety.
The IAPLPS group hopes that the list of metrics provided in
this article will streamline attempts to create effective
interinstitutional best practices for AP laboratories. Our goal
is to stimulate interest in widespread use of these metrics to
encourage standardized, revolutionary safety-management
approaches in the laboratory. LM
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